Telmisartan 40 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FXJT2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,852
Award facts
- Contract value 100% obligated
- $3,852.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan 40 mg tablets (30-count) with a ceiling value of $3,852.25 under a firm fixed-price contract structure. The award was made on June 16, 2025, with an ultimate completion date of June 17, 2025, and represents a competitively awarded, non-set-aside transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in the same city. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 value through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems worldwide.
AmerisourceBergen's DLA Troop Support Medical contract enables the company to supply a broad range of pharmaceutical products and medical supplies supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order for Telmisartan, a common antihypertensive medication, demonstrates the company's ongoing role as a critical vendor fulfilling routine pharmaceutical procurement needs for federal medical supply chains. The company's extensive contract portfolio with DLA reflects its capability to compete successfully for diverse medical commodities across multiple therapeutic domains, from specialty medications to generic drugs and medical supplies.
Quick answers
Who was awarded contract SPE2DB25FXJT2?
SPE2DB25FXJT2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 16, 2025.
How much is contract SPE2DB25FXJT2 worth?
The government has obligated $3,852 on SPE2DB25FXJT2.
Is contract SPE2DB25FXJT2 an order under another contract?
Yes. SPE2DB25FXJT2 is a delivery order under SPE2DB24D2003, an indefinite delivery contract.
Was contract SPE2DB25FXJT2 competed?
The extent of competition for SPE2DB25FXJT2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award